Reduction of transendothelial migration of mononuclear cells in interferon-β1b-treated multiple sclerosis patients

被引：0
|
作者：
Corsini, E [1 ]
Gelati, M [1 ]
Dufour, A [1 ]
Ciusani, E [1 ]
La Mantia, L [1 ]
Massa, G [1 ]
Milanese, C [1 ]
Salmaggi, A [1 ]
机构：
[1] Ist Nazl Neurol Carlo Besta, Milan, Italy
来源：
ANNALS OF NEUROLOGY | 1999年 / 46卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：435 / 435
页数：1
相关论文
共 50 条
  • [1] Glatiramer acetate in treatment-naive and prior interferon-β-1b-treated multiple sclerosis patients
    Zwibel, HL
    ACTA NEUROLOGICA SCANDINAVICA, 2006, 113 (06): : 378 - 386
  • [2] T-cell interleukin-6 receptor binding in interferon-β-1b-treated multiple sclerosis patients
    Bongioanni, P
    Lombardo, F
    Moscato, G
    Mosti, S
    Meucci, G
    EUROPEAN JOURNAL OF NEUROLOGY, 2000, 7 (06) : 647 - 653
  • [3] Serum from interferon-β-1b-treated patients with early multiple sclerosis stabilizes the blood-brain barrier in vitro
    Mueller, Marcus
    Frese, Achim
    Nassenstein, Isabelle
    Hoppen, Maike
    Marziniak, Martin
    Ringelstein, Erich Bernd
    Kim, Kwang Sik
    Schaebitz, Wolf-Ruediger
    Kraus, Joerg
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (02) : 236 - 239
  • [4] Interferon-beta (IFN-β) antibodies in interferon-β1a-and interferon-β1b-treated multiple sclerosis patients.: Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-β immunogenicity in vivo
    Perini, P
    Facchinetti, A
    Bulian, P
    Massaro, AR
    De Pascalis, D
    Bertolotto, A
    Biasi, G
    Gallo, P
    EUROPEAN CYTOKINE NETWORK, 2001, 12 (01) : 56 - 61
  • [5] Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-β 1b-treated multiple sclerosis patients
    Ferrarini, A
    Sivieri, S
    Buttarello, M
    Facchinetti, A
    Perini, P
    Gallo, P
    MULTIPLE SCLEROSIS JOURNAL, 1998, 4 (03) : 174 - 177
  • [6] Cytokines and adhesion molecules in multiple sclerosis patients treated with interferon-β1b
    Jensen, J
    Krakauer, M
    Sellebjerg, F
    CYTOKINE, 2005, 29 (01) : 24 - 30
  • [7] CD45RA+ ICAM-3+ lymphocytes in interferon-β1b-treated and -untreated patients with relapsing-remitting multiple sclerosis
    Chatzimanolis, N
    Kraus, J
    Bauer, R
    Engelhardt, B
    Bregenzer, T
    Kuehne, BS
    Tofighi, J
    Laske, C
    Stolz, E
    Blaes, F
    Voigt, K
    Traupe, H
    Kaps, M
    Oschmann, P
    ACTA NEUROLOGICA SCANDINAVICA, 2004, 110 (06): : 377 - 385
  • [8] Neutralizing antibodies in multiple sclerosis patients treated with 375 μg interferon-β-1b
    Durelli, L.
    Barbero, P.
    Cucci, A.
    Ferrero, B.
    Ricci, A.
    Contessa, G.
    De Mercanti, S.
    Ripellino, P.
    Lapuma, D.
    Viglietta, E.
    Bergui, M.
    Versino, E.
    Clerico, M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (04) : 387 - 397
  • [9] Immunomodulatory effects of interferon-β-1b in patients with multiple sclerosis
    Ossege, LM
    Sindern, E
    Patzold, T
    Malin, JP
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (06) : 1085 - 1100
  • [10] Binding antibodies to interferon-β in Iranian multiple sclerosis patients treated with different interferon-β preparations
    Vaezeafshar, R
    Hooshmand, E
    Jangouk, P
    Amirzargar, A
    Nikbin, B
    Lotfi, J
    Soltanzodeh, S
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S253 - S253
12345